acebutolol has been researched along with Body Weight in 14 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two double-blind multicenter studies compared acebutolol with placebo (acebutolol, N = 121; placebo, N = 116) and with propranolol (acebutolol, N = 186; propranolol, N = 190) in essential hypertension." | 9.05 | Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol. ( Davidov, M, 1985) |
| "A multicenter, double-blind study compared oral acebutolol (n = 186) with propranolol (n = 190) in the treatment of mild to moderately severe essential hypertension (diastolic greater than or equal to 95 to 129 mm Hg)." | 9.05 | Comparison of acebutolol and propranolol in essential hypertension. ( Singh, BN; Turlapaty, P; Wahl, J, 1985) |
| "Acebutolol was shown to be a safe, effective and reliable antihypertensive drug, at least comparable to and probably slightly better than, propranolol in the treatment of hypertension in Black Nigerians." | 6.66 | A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients. ( Abengowe, CU, 1985) |
| "Two double-blind multicenter studies compared acebutolol with placebo (acebutolol, N = 121; placebo, N = 116) and with propranolol (acebutolol, N = 186; propranolol, N = 190) in essential hypertension." | 5.05 | Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol. ( Davidov, M, 1985) |
| "A multicenter, double-blind study compared oral acebutolol (n = 186) with propranolol (n = 190) in the treatment of mild to moderately severe essential hypertension (diastolic greater than or equal to 95 to 129 mm Hg)." | 5.05 | Comparison of acebutolol and propranolol in essential hypertension. ( Singh, BN; Turlapaty, P; Wahl, J, 1985) |
| "The aim of this study was to test the efficacy of a 20 mg tablet preparation of nifedipine alone in twice daily dosage, in the treatment of moderate hypertension (95 greater than or equal to DBP less than or equal to 115 mmHg)." | 5.05 | [Antihypertensive effect of a new form of nifedipine compared to a beta-blocker during chronic administration]. ( Bénichou, M; Griener, L; Kerihuel, JC; Perchicot, E; Serradimigni, A, 1985) |
| "The effects of propranolol (100 mg/kg), atenolol (200 mg/kg) and acebutolol (1000 mg/kg) administered daily by gavage to spontaneously hypertensive rats (SHRs) from their 6th to 20th weeks of age were investigated on genetic hypertension development (GHD) and at regular intervals on heart rate (HR), cardiac output (CO), stroke volume (SV), peripheral resistence (PR), plasma renin concentration (PRC) and heart weight/body weight ratio (HW/BW)." | 3.66 | beta-Adrenoreceptor blockage and genetic hypertension development in rats. ( Boissier, JR; Giudicelli, JF; Richer, C; Venturini-Souto, N, 1980) |
| "100 hypertensive patients with chronic renal failure (initial serum creatinine 200-400 mumol/l." | 2.67 | Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. ( Chanard, J; Durand, D; el Esper, N; Fournier, A; Godin, M; Goldfarb, B; Hannedouche, T; Landais, P; Mignon, F; Suo, JM, 1994) |
| "Acebutolol was shown to be a safe, effective and reliable antihypertensive drug, at least comparable to and probably slightly better than, propranolol in the treatment of hypertension in Black Nigerians." | 2.66 | A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients. ( Abengowe, CU, 1985) |
| " Nitrendipine (mean dose 32 mg/day) and acebutolol (414 mg/day) were administered in monotherapy in increasing dosage and mefruside was added in patients not controlled by monotherapy." | 2.66 | Calcium entry blockade or beta-blockade in long-term management of hypertension in blacks. ( Amery, A; Ditu, M; Fagard, R; Lepira, B; Lijnen, P; Lissens, W; M'Buyamba-Kabangu, JR; Staessen, J; Tshiani, KA, 1987) |
| "5 mg, 25 mg, and 50 mg hydrochlorothiazide combined with 400 mg acebutolol was assessed." | 2.65 | Lack of effect of beta-blocker on flat dose response to thiazide in hypertension: efficacy of low dose thiazide combined with beta-blocker. ( Banks, RA; Bayliss, J; MacGregor, GA; Markandu, ND; Roulston, J, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (78.57) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacGregor, GA | 1 |
| Banks, RA | 1 |
| Markandu, ND | 1 |
| Bayliss, J | 1 |
| Roulston, J | 1 |
| Richer, C | 1 |
| Venturini-Souto, N | 1 |
| Boissier, JR | 1 |
| Giudicelli, JF | 1 |
| Hannedouche, T | 1 |
| Landais, P | 1 |
| Goldfarb, B | 1 |
| el Esper, N | 1 |
| Fournier, A | 1 |
| Godin, M | 1 |
| Durand, D | 1 |
| Chanard, J | 1 |
| Mignon, F | 1 |
| Suo, JM | 1 |
| Kim, Y | 1 |
| Crichton, F | 1 |
| Davidov, M | 1 |
| Abengowe, CU | 1 |
| Midol-Monnet, M | 2 |
| Heimburger, M | 2 |
| Davy, M | 2 |
| Beslot, F | 2 |
| Wepierre, J | 1 |
| Cohen, Y | 2 |
| Barre, J | 1 |
| M'Buyamba-Kabangu, JR | 2 |
| Lepira, B | 2 |
| Fagard, R | 2 |
| Lijnen, P | 2 |
| Ditu, M | 2 |
| Tshiani, KA | 2 |
| Amery, A | 2 |
| Staessen, J | 1 |
| Lissens, W | 1 |
| Wahl, J | 1 |
| Turlapaty, P | 1 |
| Singh, BN | 1 |
| Lucsko, M | 1 |
| Kerihuel, JC | 2 |
| Chaignon, M | 1 |
| Aubert, PH | 1 |
| Guedon, J | 1 |
| Serradimigni, A | 1 |
| Perchicot, E | 1 |
| Griener, L | 1 |
| Bénichou, M | 1 |
9 trials available for acebutolol and Body Weight
| Article | Year |
|---|---|
Lack of effect of beta-blocker on flat dose response to thiazide in hypertension: efficacy of low dose thiazide combined with beta-blocker.
Topics: Acebutolol; Adult; Body Weight; Chlorides; Clinical Trials as Topic; Dose-Response Relationship, Dru | 1983 |
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure.
Topics: Acebutolol; Adolescent; Adult; Aged; Atenolol; Blood Pressure; Body Weight; Enalapril; Female; Human | 1994 |
Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Body Weight; Clinical Trials as Topic; Double- | 1985 |
A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Black People; Blood Pressure; Body Weight; Dos | 1985 |
Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Black or | 1986 |
Calcium entry blockade or beta-blockade in long-term management of hypertension in blacks.
Topics: Acebutolol; Adolescent; Adult; Aged; Black or African American; Body Weight; Double-Blind Method; Dr | 1987 |
Comparison of acebutolol and propranolol in essential hypertension.
Topics: Acebutolol; Adult; Aged; Antibodies, Antinuclear; Blood Pressure; Body Weight; Clinical Trials as To | 1985 |
Comparative study of muzolimine and acebutolol in the treatment of moderate hypertension.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; | 1985 |
[Antihypertensive effect of a new form of nifedipine compared to a beta-blocker during chronic administration].
Topics: Acebutolol; Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; | 1985 |
5 other studies available for acebutolol and Body Weight
| Article | Year |
|---|---|
beta-Adrenoreceptor blockage and genetic hypertension development in rats.
Topics: Acebutolol; Animals; Atenolol; Blood Pressure; Body Weight; Depression, Chemical; Hemodynamics; Hype | 1980 |
Interaction between beta blockers and epinephrine on hemodynamics of spontaneously hypertensive rats.
Topics: Acebutolol; Adult; Animals; Body Weight; Drug Interactions; Epinephrine; Female; Hemodynamics; Human | 1993 |
Beta blockers in pregnancy and their effect on regional Doppler ultrasound and fetal weight.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Body Weight; Female; Fet | 1996 |
Acute haemodynamic effects and tissue distribution of acebutolol in normotensive and spontaneously hypertensive rats.
Topics: Acebutolol; Animals; Blood Proteins; Body Weight; Brain; Heart; Hemodynamics; Kidney; Organ Size; Pr | 1985 |
Tissue distribution of acebutolol in mature normotensive and stroke-prone spontaneously hypertensive rats.
Topics: Acebutolol; Animals; Body Weight; Carbon Radioisotopes; Male; Organ Size; Rats; Rats, Inbred SHR; Ra | 1987 |